Fibria Celulose S.A.:企業の戦略・SWOT・財務情報

◆英語タイトル:Fibria Celulose S.A. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4382
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブラジル
◆産業分野:紙・包装
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,725見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥37,450見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥56,175見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Fibria Celulose S.A. – Strategy, SWOT and Corporate Finance Report
Summary

Fibria Celulose S.A. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Fibria Celulose S.A. (Fibria) manufactures and sells short fiber pulp. The company principally focuses on the growth of sustainable and renewable forests. It also produces and sells bleached eucalyptus kraft pulp, which is used in the production of uncoated and coated papers, toilet papers for printing and writing, and coated cardboards for packaging. Fibria operates pulp manufacturing facilities at Aracruz, Tres Lagoas, Jacarei and Veracel. The company’s pulp and paper operations are carried out under Fibria brand. Its pulp products are exported across Europe, the Americas and Asia. Fibria holds forest plantations across several Brazilian states including Sao Paulo, Minas Gerais, Rio de Janeiro, Mato Grosso do Sul, Bahia and Espirito Santo. Fibria is headquartered in Sao Paulo, Brazil.

Scope

- Detailed information on Fibria Celulose S.A. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Fibria Celulose S.A. in the form of a SWOT analysis
- An in-depth view of the business model of Fibria Celulose S.A. including a breakdown and examination of key business segments
- Intelligence on Fibria Celulose S.A.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Fibria Celulose S.A., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Fibria Celulose S.A. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Fibria Celulose S.A. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Fibria Celulose S.A.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Fibria Celulose S.A.: Company Overview 9
Fibria Celulose S.A.: Overview and Key Facts 9
Fibria Celulose S.A.: Overview 9
Fibria Celulose S.A.: Key Facts 9
Fibria Celulose S.A.: Key Employees 11
Fibria Celulose S.A.: Key Employee Biographies 12
Fibria Celulose S.A.: Major Products and Services 13
Fibria Celulose S.A.: Company History 14
Fibria Celulose S.A.: Management Statement 17
Fibria Celulose S.A.: Locations and Subsidiaries 20
Fibria Celulose S.A.: Key Competitors 22
Fibria Celulose S.A.: Company Analysis 23
Fibria Celulose S.A.: Business Description 23
Fibria Celulose S.A.: SWOT Analysis 24
Fibria Celulose S.A.: SWOT Overview 24
Fibria Celulose S.A.: Strengths 24
Fibria Celulose S.A.: Weaknesses 25
Fibria Celulose S.A.: Opportunities 25
Fibria Celulose S.A.: Threats 26
Fibria Celulose S.A.: Corporate Financial Deals Activity 27
Fibria Celulose S.A.: Financial Deals Overview 27
Fibria Celulose S.A.: Targets and Partners 29
Fibria Celulose S.A.: Top Deals 2014 – 2018YTD* 30
Fibria Celulose S.A.: Advisors 31
Fibria Celulose S.A.: Top Legal Advisors 31
Fibria Celulose S.A.: Top Financial Advisors 31
Fibria Celulose S.A.: Mergers and Acquisitions 32
Fibria Celulose S.A.: Capital Raising 33
Fibria Celulose S.A.: Recent Developments 34
Fibria Celulose S.A.: News and Events Summary 34
Fibria Celulose S.A.: Business Expansion 35
Fibria Celulose S.A.: Contracts 37
Fibria Celulose S.A.: Financial Performance 38
Fibria Celulose S.A.: Strategy and Operations 38
Appendix 40
Contact Us 40
Methodology 40
About MarketLine 41

List of Tables
Table 1: Fibria Celulose S.A.: Key Facts
Table 2: Fibria Celulose S.A.: Key Employees
Table 3: Fibria Celulose S.A.: Locations and Subsidiaries
Table 4: Fibria Celulose S.A.: Key Competitors
Table 5: Fibria Celulose S.A.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Fibria Celulose S.A.: M&A Activity by Geography (TTM*)
Table 7: Fibria Celulose S.A.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Fibria Celulose S.A.: M&A Average Deal Size - Value (US$m)
Table 9: Fibria Celulose S.A.: Targets and Partners
Table 10: Fibria Celulose S.A.: Top Deals 2014 - 2018YTD*
Table 11: Fibria Celulose S.A.: Legal Advisor Ranking by Value (US$m)
Table 12: Fibria Celulose S.A.: Financial Advisor Ranking by Value (US$m)
Table 13: Fibria Celulose S.A.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Fibria Celulose S.A.: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Fibria Celulose S.A.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 16: Fibria Celulose S.A.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 17: Fibria Celulose S.A.: News and Events Summary
Table 18: Fibria Celulose S.A.: Business Expansion
Table 19: Fibria Celulose S.A.: Contracts
Table 20: Fibria Celulose S.A.: Financial Performance
Table 21: Fibria Celulose S.A.: Strategy and Operations

List of Figures
Figure 1: Fibria Celulose S.A.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Fibria Celulose S.A.: M&A Activity by Geography (TTM*)
Figure 3: Fibria Celulose S.A.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Fibria Celulose S.A.: M&A Average Deal Size - Value (US$m)
Figure 5: Fibria Celulose S.A.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Fibria Celulose S.A.: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Fibria Celulose S.A.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 8: Fibria Celulose S.A.: Capital Raising by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Fibria Celulose S.A.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Euroscreen S.A.(製薬・医療分野):企業M&A動向
    Summary Euroscreen S.A. (Euroscreen) is a preclinical-stage, drug discovery and development company. It provides small molecule drug candidates to address several unmet medical needs. The company’s product pipeline spans ESN364 which targets sex hormone disorders, ESN282 which addresses inflammation …
  • Dong Wha Pharma Co., Ltd. (000020):企業概要、財務及び戦略的SWOT分析
    Summary Dong wha Pharm Co., Ltd. (Dongwha Pharm) is a pharmaceutical company. The company carries out research, development, manufacture and marketing of healthcare products. It offers products through the divisions such as Ethical Drugs, Over-the-Counter (OTC) products, Health Subsidiary Foods, Med …
  • Neftegazovaya Kompaniya Slavneft (SLAV):企業概要、財務及び戦略的SWOT分析
    Summary Neftegazovaya Kompaniya Slavneft (OAO NGK Slavneft) is an oil and gas company. The company produces, sells and distributes oil products from exploration of hydrocarbon reserves and final oil products. Its products include oil and natural gas. The company has oil and gas exploration, developm …
  • Gunvor Group Limited:企業の戦略的SWOT分析
    Gunvor Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Stemline Therapeutics Inc (STML):製薬・医療:M&Aディール及び事業提携情報
    Summary Stemline Therapeutics Inc (Stemline) is a clinical stage biopharmaceutical company that develops therapeutics to treat cancer stem cells and tumor bulk. The company has developed discovery platform StemScreen to identify novel compounds that target and kill cancer stem cells. Its products pi …
  • Miragen Therapeutics Inc (MGEN):製薬・医療:M&Aディール及び事業提携情報
    Summary Miragen Therapeutics, Inc. (Miragen) is a clinical stage biopharmaceutical company. It discovers and develops RNA-targeted therapeutics with a focus on microRNAs and their role in diseases. The company is developing its pipeline products for the treatment of Cutaneous T-Cell Lymphoma (CTCL), …
  • Cross Cat Co., Ltd. (2307):企業財務及び戦略的SWOT分析
    Summary Cross Cat Co., Ltd. (Cross Cat) is an information technology company that offers system solutions and services. The company offers services such as BI business consulting, IT platform construction and operation, and system development solutions. It offers its system development services to c …
  • Triodos Bank NV:企業の戦略・SWOT・財務情報
    Triodos Bank NV - Strategy, SWOT and Corporate Finance Report Summary Triodos Bank NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Merck Sharp and Dohme Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Merck Sharp and Dohme Limited M …
  • Amcor Limited:企業の戦略・SWOT・財務情報
    Amcor Limited - Strategy, SWOT and Corporate Finance Report Summary Amcor Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Cadila Healthcare Ltd (CADILAHC):企業の財務・戦略的SWOT分析
    Cadila Healthcare Ltd (CADILAHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Health Care REIT, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Health Care REIT, Inc. Mergers …
  • Revance Therapeutics, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Revance Therapeutics, Inc. (Revance) is a bio-pharmaceutical company. The company develops, manufactures and commercializes novel botulinum toxin products for multiple aesthetic and therapeutic applications. Its products include RT001, a physician-applied topical botulinum toxin type A (BoNT …
  • Craneware plc (CRW):企業概要、財務及び戦略的SWOT分析
    Summary Craneware plc (Craneware) is a healthcare IT company. The company provides healthcare technology solutions. Its product categories include Revenue Cycle, Access Management and Strategic Pricing, Supply Management and Audit and Revenue Recovery. Craneware’s products include Chargemaster Toolk …
  • Linde AG (LIN):企業のM&A・提携動向(石油・ガス分野)
    Summary Linde AG (Linde) is an industrial gases and engineering company. It produces and markets different industrial gases and offers facilities and equipment for gas applications. Linde offers various products including atmospheric gases, fuel gases, shielding gases, electronic gases and chemicals …
  • United Insurance Limited (UNIN):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "United Insurance Limited" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly …
  • Hubei Guangji Pharmaceutical Co., Ltd. (000952):企業概要、財務及び戦略的SWOT分析
    Summary Hubei Guangji Pharmaceutical Co., Ltd. (GJPC) is a pharmaceutical company. The company manufactures and markets pharmaceutical raw materials. Its product categories include active pharmaceutical ingredients, human nutrition and animal nutrition. GJPC offers products such as beta-carotene, Ri …
  • Group 1 Automotive, Inc.:企業のM&A・事業提携・投資動向
    Group 1 Automotive, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Group 1 Automotive, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • I.Ceram SA (ALICR):医療機器:M&Aディール及び事業提携情報
    Summary I.Ceram SA (I.Ceram) is a medical equipment and device company that designs, manufactures, and markets joint implants for neurosurgery and other surgical procedures. The company’s products include bone fillers, alumina bio-ceramic implants, trepan caps, cervical plates and blocks for cervica …
  • Imation Corp.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Imation Corp. Mergers and Acqui …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆